Skip to content

STEMPOINT CAPITAL LP

Follow

13F filer, CIK 1952142, NEW YORK, NY

STEMPOINT CAPITAL LP reported $559,545,201 across 91 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 39.5% of the portfolio.

Accepted , ingested 13F-HR 0001420506-26-002774

Period
2026-09-30
Reported value
$560M
Holdings
91
Top 10 weight
39.5%
New
47
Sold out
40

Part of the filer group STEMPOINT CAPITAL LP

  • Michelle Ross
  • StemPoint Capital Management GP LLC
How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SRRKadded+449,808$21.7M
ADPTnew+463,551$13.4M
FTHnew+404,921$12M
IMTXnew+1,308,193$11.5M
GRALnew+81,924$11.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
RVMDreduced-109,943-$22.6M
TYRAexited-632,754-$20.2M
KNSAreduced-157,430-$11.7M
BIOAexited-464,171-$11.4M
MLYSreduced-402,686-$10.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001420506-26-002774, largest first. % of portfolio is the value over $558,427,901, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 166,307 shares; 2025Q1: 566,212 shares; 2025Q2: 528,115 shares; 2025Q3: 726,204 shares; 2025Q4: 886,893 shares; 2026Q1: 1,035,496 shares; 2026Q2: 239,146 shares; 2026Q3: 688,954 shares 688,954$33.3M5.96%+449,808Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 239,861 shares; 2026Q2: 1,565,913 shares; 2026Q3: 2,260,594 shares 2,260,594$33.1M5.93%+694,681Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 87,748 shares; 2025Q3: 166,273 shares; 2025Q4: 391,783 shares; 2026Q1: 313,791 shares; 2026Q2: 283,657 shares; 2026Q3: 279,398 shares 279,398$27.7M4.95%-4,259Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 208,800 shares; 2025Q3: 245,378 shares; 2025Q4: not reported; 2026Q1: 200,919 shares; 2026Q2: 1,223,019 shares; 2026Q3: 989,345 shares 989,345$24.7M4.42%-233,674Timeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,712,778 shares; 2025Q1: 2,578,860 shares; 2025Q2: 601,781 shares; 2025Q3: 4,197,187 shares; 2025Q4: 966,698 shares; 2026Q1: 385,800 shares; 2026Q2: 348,408 shares; 2026Q3: 641,473 shares 641,473$23.5M4.2%+293,065Timeline
TRAXFIRST TRACKS BIOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 622,723 shares; 2026Q3: 649,924 shares 649,924$23M4.12%+27,201Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 96,716 shares; 2025Q1: 120,430 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 363,438 shares; 2026Q2: 346,914 shares; 2026Q3: 330,476 shares 330,476$15.1M2.71%-16,438Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 416,968 shares; 2025Q1: 192,352 shares; 2025Q2: 351,124 shares; 2025Q3: 241,637 shares; 2025Q4: not reported; 2026Q1: 80,492 shares; 2026Q2: 248,015 shares; 2026Q3: 333,332 shares 333,332$13.5M2.42%+85,317Timeline
ADPTADAPTIVE BIOTECHNOLOGIES CORQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 606,825 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 463,551 shares 463,551$13.4M2.4%newTimeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 41,382 shares; 2025Q4: 79,284 shares; 2026Q1: 85,502 shares; 2026Q2: 200,851 shares; 2026Q3: 150,776 shares 150,776$13.3M2.38%-50,075Timeline
FTHFAETH THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 132,873 shares; 2026Q2: not reported; 2026Q3: 404,921 shares 404,921$12M2.16%newTimeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 136,139 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 32,377 shares; 2026Q1: 167,606 shares; 2026Q2: 106,926 shares; 2026Q3: 132,238 shares 132,238$11.8M2.11%+25,312Timeline
IMTXIMMATICS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 610,308 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,308,193 shares 1,308,193$11.5M2.06%newTimeline
GRALGRAIL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 81,924 shares 81,924$11.5M2.06%newTimeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 134,178 shares; 2025Q1: not reported; 2025Q2: 32,255 shares; 2025Q3: not reported; 2025Q4: 21,067 shares; 2026Q1: 56,267 shares; 2026Q2: 37,243 shares; 2026Q3: 38,720 shares 38,720$11.3M2.02%+1,477Timeline
SRZNSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 350,573 shares; 2025Q1: 240,826 shares; 2025Q2: 686,539 shares; 2025Q3: 713,463 shares; 2025Q4: 619,766 shares; 2026Q1: 525,639 shares; 2026Q2: 602,798 shares; 2026Q3: 418,527 shares 418,527$11.1M1.99%-184,271Timeline
CCCCC4 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 453,236 shares; 2026Q2: 523,648 shares; 2026Q3: 3,293,376 shares 3,293,376$11M1.96%+2,769,728Timeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,050,698 shares 2,050,698$10.8M1.93%newTimeline
DMRADAMORA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 506,067 shares 506,067$10.8M1.93%newTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 193,535 shares; 2025Q1: 318,782 shares; 2025Q2: not reported; 2025Q3: 185,380 shares; 2025Q4: 62,032 shares; 2026Q1: 281,632 shares; 2026Q2: 159,943 shares; 2026Q3: 50,000 shares 50,000$10.3M1.84%-109,943Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 83,576 shares; 2025Q1: 149,648 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 146,978 shares; 2026Q1: 129,577 shares; 2026Q2: 75,603 shares; 2026Q3: 145,760 shares 145,760$9.61M1.72%+70,157Timeline
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 25,051 shares 25,051$9.17M1.64%newTimeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 375,845 shares; 2025Q1: 274,633 shares; 2025Q2: not reported; 2025Q3: 192,295 shares; 2025Q4: 348,605 shares; 2026Q1: 140,755 shares; 2026Q2: 76,075 shares; 2026Q3: 222,287 shares 222,287$8.27M1.48%+146,212Timeline
JNJJOHNSON & JOHNSONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 35,000 shares; 2026Q1: 15,415 shares; 2026Q2: not reported; 2026Q3: 30,000 shares 30,000$7.94M1.42%newTimeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 350,710 shares; 2025Q4: 399,557 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 552,245 shares 552,245$7.91M1.42%newTimeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,759 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 6,599 shares 6,599$7.64M1.37%newTimeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 39,198 shares; 2026Q3: 109,926 shares 109,926$7.19M1.29%+70,728Timeline
CERSCERUS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,967,942 shares 2,967,942$7.06M1.26%newTimeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,118,508 shares; 2025Q1: 853,472 shares; 2025Q2: 1,300,860 shares; 2025Q3: 1,589,580 shares; 2025Q4: 644,959 shares; 2026Q1: 746,494 shares; 2026Q2: 276,527 shares; 2026Q3: 201,334 shares 201,334$6.8M1.22%-75,193Timeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 154,034 shares; 2026Q2: not reported; 2026Q3: 471,718 shares 471,718$6.63M1.19%newTimeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 33,527 shares 33,527$5.98M1.07%newTimeline
OABIOMNIAB INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,204,038 shares 1,204,038$5.97M1.07%newTimeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 184,173 shares 184,173$5.9M1.06%newTimeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 186,413 shares; 2025Q1: 250,564 shares; 2025Q2: 174,754 shares; 2025Q3: 1,017,311 shares; 2025Q4: not reported; 2026Q1: 1,594,491 shares; 2026Q2: 1,064,200 shares; 2026Q3: 396,865 shares 396,865$5.3M0.95%-667,335Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 400,101 shares; 2025Q1: not reported; 2025Q2: 631,586 shares; 2025Q3: 158,112 shares; 2025Q4: 290,049 shares; 2026Q1: 533,378 shares; 2026Q2: 602,686 shares; 2026Q3: 200,000 shares 200,000$5.03M0.9%-402,686Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 66,999 shares; 2025Q2: 165,885 shares; 2025Q3: 371,825 shares; 2025Q4: 161,659 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 123,760 shares 123,760$4.75M0.85%newTimeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 136,710 shares; 2025Q4: 118,333 shares; 2026Q1: 60,062 shares; 2026Q2: 98,203 shares; 2026Q3: 57,880 shares 57,880$4.6M0.82%-40,323Timeline
GHRSGH RESEARCH PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 100,826 shares; 2025Q3: 545,275 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 195,143 shares 195,143$4.58M0.82%newTimeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 132,706 shares; 2025Q1: 180,255 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 360,876 shares; 2026Q1: 290,864 shares; 2026Q2: not reported; 2026Q3: 111,577 shares 111,577$4.53M0.81%newTimeline
IFRXINFLARX NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 725,019 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,228,255 shares; 2026Q3: 2,485,233 shares 2,485,233$4.47M0.8%-743,022Timeline
IPSCCENTURY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,146,182 shares; 2026Q3: 2,563,862 shares 2,563,862$4.38M0.79%+417,680Timeline
BDSXBIODESIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 70,004 shares; 2026Q2: 70,000 shares; 2026Q3: 141,548 shares 141,548$4.22M0.76%+71,548Timeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 61,403 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 42,200 shares 42,200$4.15M0.74%newTimeline
SNYSANOFI SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 99,880 shares 99,880$4.12M0.74%newTimeline
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 714,280 shares; 2026Q3: 647,406 shares 647,406$4.07M0.73%-66,874Timeline
CGONCG ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 289,823 shares; 2025Q2: not reported; 2025Q3: 63,019 shares; 2025Q4: not reported; 2026Q1: 205,622 shares; 2026Q2: 159,349 shares; 2026Q3: 54,791 shares 54,791$3.88M0.7%-104,558Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 104,585 shares; 2025Q2: 152,652 shares; 2025Q3: 150,573 shares; 2025Q4: 73,106 shares; 2026Q1: 180,658 shares; 2026Q2: 77,589 shares; 2026Q3: 159,044 shares 159,044$3.87M0.69%+81,455Timeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 209,234 shares; 2026Q3: 51,804 shares 51,804$3.87M0.69%-157,430Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 154,320 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 187,320 shares 187,320$3.86M0.69%newTimeline
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 200,836 shares 200,836$3.83M0.69%newTimeline
LBRXLB PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 50,000 shares; 2026Q2: 31,785 shares; 2026Q3: 91,757 shares 91,757$3.47M0.62%+59,972Timeline
EDSAEDESA BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 825,000 shares 825,000$3.47M0.62%newTimeline
AVLNAVALYN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 118,000 shares; 2026Q3: 118,000 shares 118,000$3.36M0.6%0Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 8,087 shares 8,087$3.29M0.59%newTimeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 315,226 shares; 2026Q2: not reported; 2026Q3: 137,973 shares 137,973$3.27M0.59%newTimeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,417,283 shares; 2026Q3: 1,287,804 shares 1,287,804$3.21M0.57%-1,129,479Timeline
CUECUE BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 66,995 shares; 2026Q3: 108,647 shares 108,647$2.81M0.5%+41,652Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 6,264 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,646 shares 4,646$2.52M0.45%newTimeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 84,430 shares; 2025Q2: not reported; 2025Q3: 474,612 shares; 2025Q4: 835,200 shares; 2026Q1: 506,075 shares; 2026Q2: not reported; 2026Q3: 154,234 shares 154,234$2.48M0.44%newTimeline
ATTOATTOVIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 138,200 shares 138,200$2.37M0.42%newTimeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 116,461 shares; 2026Q3: 27,260 shares 27,260$2.27M0.41%-89,201Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 106,610 shares; 2025Q1: 87,059 shares; 2025Q2: 61,578 shares; 2025Q3: 43,419 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 19,603 shares 19,603$2.24M0.4%newTimeline
WGSGENEDX HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 29,275 shares 29,275$2.12M0.38%newTimeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 58,389 shares; 2026Q1: 86,637 shares; 2026Q2: 80,907 shares; 2026Q3: 66,320 shares 66,320$2.1M0.38%-14,587Timeline
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 424,082 shares; 2025Q4: 1,458,807 shares; 2026Q1: 939,369 shares; 2026Q2: 1,021,037 shares; 2026Q3: 495,980 shares 495,980$1.86M0.33%-525,057Timeline
MNPRMONOPAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 30,125 shares; 2026Q3: 23,302 shares 23,302$1.86M0.33%-6,823Timeline
HLXCHELIX ACQUISITION CORP IIIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 305,028 shares; 2026Q2: 171,671 shares; 2026Q3: 171,671 shares 171,671$1.82M0.33%0Timeline
ARQTARCUTIS BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 500,966 shares; 2025Q1: 440,073 shares; 2025Q2: 205,672 shares; 2025Q3: 411,893 shares; 2025Q4: 224,740 shares; 2026Q1: 413,792 shares; 2026Q2: 98,945 shares; 2026Q3: 61,189 shares 61,189$1.62M0.29%-37,756Timeline
AEMDAETHLON MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 213,685 shares 213,685$1.39M0.25%newTimeline
TCGXTCGX ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000$1.25M0.22%newTimeline
SABSSAB BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 146,558 shares; 2026Q1: 375,000 shares; 2026Q2: 342,631 shares; 2026Q3: 352,689 shares 352,689$1.12M0.2%+10,058Timeline
JTTTJATT III ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000$1.1M0.2%newTimeline
QNRXQUOIN PHARMACEUTICALS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 236,234 shares 236,234$1.08M0.19%newTimeline
ADRXADARX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 52,000 shares 52,000$1.04M0.19%newTimeline
STLNSTARLING ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 156,663 shares 156,663$990K0.18%newTimeline
CLRBCELLECTAR BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 354,938 shares; 2026Q3: 447,360 shares 447,360$823K0.15%+92,422Timeline
ANROALTO NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 21,763 shares 21,763$556K0.1%newTimeline
CALCCALCIMEDICA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 248,972 shares 248,972$403K0.07%newTimeline
BRVEBRAVEHEART BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 10,000 shares 10,000$202K0.04%newTimeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 597,409 shares; 2026Q2: 1,460,093 shares; 2026Q3: 44,129 shares 44,129$166K0.03%-1,415,964Timeline
VTGNVISTAGEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,328,492 shares; 2025Q1: 2,366,554 shares; 2025Q2: 2,413,254 shares; 2025Q3: 2,488,685 shares; 2025Q4: 616,749 shares; 2026Q1: 616,749 shares; 2026Q2: 616,749 shares; 2026Q3: 337,939 shares 337,939$24.7K<0.01%-278,810Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
QQQINVESCO QQQ TR COMput60,000$255Knew
SPYSTATE STR SPDR S&P 500 ETF T SHSput75,000$226Knew
BNTXBIONTECH SE ADRcall25,000$144Knew
RVMDREVOLUTION MEDICINES INC Stockcall10,000$106Knew
ARKGARK ETF TR GENOMIC REV ETFput450,000$102K+350,000
SMMTSUMMIT THERAPEUTICS INC COMcall75,000$88.1Knew
XBISPDR SERIES TRUST S&P BIOTECHput375,000$71.2K+125,000
JNJJOHNSON & JOHNSON COMput30,000$55.5Knew
GHGUARDANT HEALTH INC Stockput15,000$52.5Knew
ERASERASCA INC Stockcall45,000$15.8Knew

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
TYRATYRA BIOSCIENCES INC632,754$20.2Mshares
BIOABIOAGE LABS INC464,171$11.4Mshares
CLYMCLIMB BIO INC742,745$9.69Mshares
ZURAZURA BIO LTD1,368,215$8.07Mshares
AMLXAMYLYX PHARMACEUTICALS INC384,304$6.9Mshares
CLDXCELLDEX THERAPEUTICS INC NEW178,412$6.64Mshares
EQEQUILLIUM INC2,016,607$6.45Mshares
DFTXDEFINIUM THERAPEUTICS INC137,124$6.45Mshares
DMRADAMORA THERAPEUTICS INC216,194$5.62Mshares
IVAINVENTIVA SA1,426,320$5.39Mshares
EYPTEYEPOINT INC338,471$4.84Mshares
ASMBASSEMBLY BIOSCIENCES INC170,378$4.68Mshares
QUREUNIQURE NV88,115$4.06Mshares
CMPSCOMPASS PATHWAYS PLC284,769$4.03Mshares
MPLTMAPLIGHT THERAPEUTICS INC106,906$3.83Mshares
ALMSALUMIS INC135,736$3.82Mshares
AXSMAXSOME THERAPEUTICS INC.15,375$3.76Mshares
GLUEMONTE ROSA THERAPEUTICS INC153,544$3.72Mshares
ACADACADIA PHARMACEUTICALS INC143,167$3.62Mshares
SLDBSOLID BIOSCIENCES INC358,780$3.58Mshares
PSNLPERSONALIS INC247,783$3.32Mshares
CBIOCRESCENT BIOPHARMA INC.182,382$3.28Mshares
KODKODIAK SCIENCES INC75,872$2.96Mshares
RAPPRAPPORT THERAPEUTICS INC66,582$2.77Mshares
SIONSIONNA THERAPEUTICS INC59,426$2.61Mshares
SPRBSPRUCE BIOSCIENCES INC41,388$2.23Mshares
GPCRSTRUCTURE THERAPEUTICS INC38,178$2.05Mshares
PTGXPROTAGONIST THERAPEUTICS INC16,303$2Mshares
TENXTENAX THERAPEUTICS INC96,273$1.4Mshares
CALCCALCIMEDICA INC1,244,864$1.2Mshares
PSNLPERSONALIS INC470,000$811Kcall
PRQRPROQR THRAPEUTICS N V431,054$802Kshares
BHVNBIOHAVEN LTD500,000$525Kcall
AZNASTRAZENECA PLC25,000$180Kcall
XBISPDR SERIES TRUST400,000$178Kcall
TNGXTANGO THERAPEUTICS INC100,000$175Kcall
RVMDREVOLUTION MEDICINES INC30,000$128Kput
ERASERASCA INC200,000$90Kput
ROIVROIVANT SCIENCES LTD100,000$40Kput
AMGNAMGEN INC15,000$15Kput

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-26-002774 base2026-11-16

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001420506-26-002774 Quarter ended 2026-09-302026-11-16
13G/A 0001104659-26-127781 SRZN2026-11-16
13G 0001104659-26-127778 QNRX2026-11-16
13G 0001104659-26-127774 EDSA2026-11-16
13G 0001104659-26-127771 CALC2026-11-16
13F-HR 0001420506-26-001687 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR/A 0001420506-26-001177 Quarter ended 2026-03-312026-05-18acceptance time not in the bulk data set
13F-HR 0001420506-26-001107 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001420506-26-000490 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR 0001420506-25-003308 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001420506-25-002033 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001420506-25-001189 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0001420506-25-000514 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001420506-24-002386 Quarter ended 2024-09-302024-11-13acceptance time not in the bulk data set
13F-HR 0001420506-24-001376 Quarter ended 2024-06-302024-08-13acceptance time not in the bulk data set
13F-HR/A 0001420506-24-001418 Quarter ended 2024-06-302024-08-13acceptance time not in the bulk data set
13F-HR/A 0001420506-24-001315 Quarter ended 2024-03-312024-08-09acceptance time not in the bulk data set
13F-HR 0001420506-24-000808 Quarter ended 2024-03-312024-05-14acceptance time not in the bulk data set
13F-HR 0001420506-24-000248 Quarter ended 2023-12-312024-02-13acceptance time not in the bulk data set